43 results on '"Yang, Ju Dong"'
Search Results
2. Tu1544 CLINICAL BENEFITS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE IN A CONTEMPORARY COHORT OF AT-RISK PATIENTS.
3. Su1523 THE PREVALENCE OF PNPLA3 GENETIC VARIANT IN CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN THE UNITED STATES.
4. Sa1538 AWARENESS OF ADVANCED FIBROSIS AND CIRRHOSIS IN THE UNITED STATES: A NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2017-2020.
5. Sa1557 EFFECTS OF METABOLIC RISK FACTORS ON THE RISK OF PROGRESSION TO CIRRHOSIS AND HEPATOCELLULAR CARCINOMA.
6. Sa1428 FEASIBILTY OF REAL-TIME TRANSDERMAL ALCOHOL MEASUREMENTS IN PANCREATITIS PATIENTS.
7. Tu1550 UTILITY OF A BIOMARKER-DERIVED SCORE FOR TREATMENT RESPONSE ASSESSMENT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.
8. Tu1551 COST-EFFECTIVENESS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE PROGRAMS USING MULTI-TARGET BLOOD TEST.
9. 340 COVID-19 PANDEMIC IMPACT ON DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN THE UNITED STATES.
10. Sa1149 MULTIDISCIPLINARY CARE FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
11. Liver Mass in a Young Male With Ollier Disease.
12. Fr390 COMPARISON OF SURGICAL RESECTION AND SYSTEMIC TREATMENT FOR HEPATOCELLULAR CARCINOMA WITH VASCULAR INVASION: NATIONAL CANCER DATABASE ANALYSIS.
13. Fr388 THERAPEUTIC UNDERUTILIZATION AND DELAY IN HEPATOCELLULAR CARCINOMA: TRENDS, ASSOCIATED FACTORS AND THEIR CLINICAL IMPACT FROM NATIONAL CANCER DATABASE ANALYSIS.
14. 433 THE ASSOCIATION OF SUSTAINED VIROLOGIC RESPONSE ON TREATMENT OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA WITH HEPATITIS C.
15. Mo1416 - Effect of Coffee Consumption on Cholangiocarcinoma Risk and Survival.
16. 224 - Detection of Cholangiocarcinoma by Assay of Methylated DNA Markers in Plasma.
17. 904 - Significantly Lower Rates of Cirrhosis and Lower Long-Term Survival in Cryptogenic Hepatocellular Carcinoma (HCC) Compared to Viral Etiologies: Results of a Multi-Center International Cohort.
18. Mo1410 - Race Specific Trends in Incidence Rates of Hepatocellular Carcinoma in the United States.
19. Sa1478 - High Prevalence of Viral Hepatitis B and C Infection among Minnesota's Somali Community.
20. Mo1421 - Male Sex is a Risk Factor for Poorer Long-Term Overall Survival for White Patients with Hepatocellular Carcinoma (HCC) but not for Black Patients with HCC.
21. Mo1406 - Racial and Socioeconomic Disparities in the Incidence Rates and Survival of Gallbladder Cancer in the United States.
22. Mo1409 - Black Patients with Hepatocellular Carcinoma (HCC) Diagnosed After 2010 have Worse Long-Term Survival Than White Patients.
23. Mo1515 Recent Trends in HCC Epidemiology in Olmsted County, Minnesota.
24. Sa1128 Hepatocellular Carcinoma Characteristics and Outcomes among Somali Immigrants vs. Non-Hispanic Whites.
25. 647 Validation of the GALAD Score for Prediction of Hepatocellular Carcinoma at a US Tertiary Referral Center and Comparison of its Performance to Liver Ultrasound.
26. 651 Impact of Country of Birth on the Age of Onset of Hepatocellular Carcinoma in the United States.
27. Mo1510 Prognosis of Patients With Hepatocellular Carcinoma Is Extremely Poor in African Country.
28. 13 Differential Characteristics of Black and White Patients With Hepatocellular Carcinoma (HCC).
29. Mo1498 Non-Alcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma (HCC) in Maritime South East Asians (MSEAS).
30. Mo1479 Serum Alpha Fetoprotein in Hepatocellular Carcinoma: Effect of Etiology, Race, and Severity of Liver Inflammation.
31. Mo1495 Hepatocellular Carcinoma in South America: Predominance of Hepatitis C Etiology and Late Diagnosis.
32. 584 Circulating Tumor Cells Are Associated With Poor Overall Survival in Patients With Cholangiocarcinoma.
33. 582 Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B.
34. 639 Female Gender Associated With Less Aggressive Tumor Phenotype and Better Survival in HCC.
35. Sa1043 Associations of Sex and Menopause With Histologic Severity of Necroinflammation and Portal Inflammation Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD).
36. Su2056 Associations Between Etiology, Tumor Extent, and Alpha Fetoprotein in Patients With Hepatocellular Carcinoma.
37. 597 Risk Factors for Intrahepatic Cholangiocarcinoma (ICC): Associations Between Metformin or Statin use and Reduced Cancer Risk.
38. Obesity is Not a Risk Factor for Hepatocellular Carcinoma in Patients With Cirrhosis.
39. Circulating Tumor Cells in Cholangiocarcinoma.
40. Transarterial Radioembolization in Advanced Stage Hepatocellular Carcinoma.
41. S1902 Liver Fibrosis in Patients With Hepatocellular Carcinoma: Comparison Between Hepatitis B and C.
42. 843 SULF1 and SULF2 Correlated Genes in Hepatocellular Carcinoma (HCC) as Revealed by Genome-Wide Gene Expression Microarray Analysis.
43. Print and Media Review: Malignant Liver Tumors: Current and Emerging Therapies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.